{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T17:59:04Z","timestamp":1771869544312,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020821","name":"Monash Biomedicine Discovery Institute, Monash University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020821","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013885","name":"Ministry of Health Malaysia","doi-asserted-by":"publisher","award":["NMRR-19-3938-45763"],"award-info":[{"award-number":["NMRR-19-3938-45763"]}],"id":[{"id":"10.13039\/501100013885","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004595","name":"Universiti Sains Malaysia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["MethodsX"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.mex.2025.103167","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T02:52:38Z","timestamp":1736477558000},"page":"103167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Adaptation of an in vitro one-compartment pharmacodynamic chemostat for testing efficacy of ceftazidime against Burkholderia pseudomallei outside a BSL3 facility"],"prefix":"10.1016","volume":"14","author":[{"given":"Hana Farizah","family":"Zamri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Ridhuan","family":"Mohd Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad Izzan Irfan","family":"Sha'ari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurul Husna","family":"Mohd Mazalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norazah","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nur Asyura","family":"Nor Amdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nusaibah","family":"Abdul Rahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3344-1518","authenticated-orcid":false,"given":"Zakuan Zainy","family":"Deris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mex.2025.103167_bib0001","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S1473-3099(19)30157-4","article-title":"Global burden of melioidosis in 2015: a systematic review and data synthesis","volume":"19","author":"Birnie","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.mex.2025.103167_bib0002","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/tropicalmed3010025","article-title":"Melioidosis in Malaysia: incidence, clinical challenges, and advances in understanding pathogenesis","volume":"3","author":"Nathan","year":"2018","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.mex.2025.103167_bib0003","article-title":"Pharmacodynamic parameters of pharmacokinetic\/pharmacodynamic (PK\/PD) integration models","volume":"24","author":"Zhang","year":"2022","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.mex.2025.103167_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2022.106616","article-title":"Pharmacokinetic\/pharmacodynamic models for time courses of antibiotic effects","volume":"60","author":"Minichmayr","year":"2022","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.mex.2025.103167_bib0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ddtec.2016.08.004","article-title":"Translational PK\/PD of anti-infective therapeutics","volume":"22","author":"Rathi","year":"2016","journal-title":"Drug. Discov. Today Technol."},{"key":"10.1016\/j.mex.2025.103167_bib0006","doi-asserted-by":"crossref","first-page":"e02307","DOI":"10.1128\/AAC.02307-18","article-title":"Generating robust and informative nonclinical in vitro and in vivo bacterial infection model efficacy data to support translation to humans","volume":"63","author":"Bulitta","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mex.2025.103167_bib0007","unstructured":"CDC Health Advisory. Melioidosis locally endemic in areas of the Mississippi gulf coast [Internet]. 2022 [cited 2024 Dec 18]. Available from: https:\/\/www.cdc.gov\/han\/2022\/han00470.html"},{"key":"10.1016\/j.mex.2025.103167_bib0008","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0195-6701(92)90140-H","article-title":"Melioidosis and safety in the clinical laboratory","volume":"21","author":"Ashdown","year":"1992","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/j.mex.2025.103167_bib0009","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00424-21","article-title":"Laboratory safety: handling Burkholderia pseudomallei Isolates without a Biosafety Cabinet","volume":"59","author":"Gassiep","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.mex.2025.103167_bib0010","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijregi.2023.11.014","article-title":"Assessing the national antibiotic surveillance data to identify burden for melioidosis in Malaysia","volume":"10","author":"Arushothy","year":"2023","journal-title":"IJID Reg."},{"key":"10.1016\/j.mex.2025.103167_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.747894","article-title":"Applying the hierarchy of controls: what occupational safety can teach us about safely navigating the next phase of the global COVID-19 pandemic","volume":"9","author":"Sehgal","year":"2021","journal-title":"Front. Public Health"},{"key":"10.1016\/j.mex.2025.103167_bib0012","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1128\/AAC.13.4.570","article-title":"New in vitro model to study the effect of antibiotic concentration and rate of elimination on antibacterial activity","volume":"13","author":"Grasso","year":"1978","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mex.2025.103167_bib0013","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1128\/AAC.01046-07","volume":"52","author":"LaPlante","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mex.2025.103167_bib0014","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1365-2125.2000.00179.x","article-title":"Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis","volume":"50","author":"Angus","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.mex.2025.103167_bib0015","series-title":"A Practice of Anesthesia for Infants and Children","first-page":"100","article-title":"Pharmacokinetics and pharmacology of drugs used in children","author":"Anderson","year":"2018"},{"key":"10.1016\/j.mex.2025.103167_bib0016","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s40484-018-0143-8","article-title":"Developing a low-cost milliliter-scale chemostat array for precise control of cellular growth","volume":"6","author":"Skelding","year":"2018","journal-title":"Quant. Biol."},{"key":"10.1016\/j.mex.2025.103167_bib0017","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1590\/S0103-50532007000200023","article-title":"A rapid method to determine antibiotic residues in milk using liquid chromatography coupled to electrospray tandem mass spectrometry","volume":"18","author":"Martins-J\u00fanior","year":"2007","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.mex.2025.103167_bib0018","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/antibiotics11010054","article-title":"Quantification of fosfomycin in combination with nine antibiotics in human plasma and cation-adjusted Mueller-Hinton II broth via LCMS","volume":"11","author":"Goh","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.mex.2025.103167_bib0019","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/ja.2014.73","article-title":"LC-MS\/MS determination of colistin in Mueller-Hinton broth for in vitro pharmacodynamic studies","volume":"67","author":"Zhao","year":"2014","journal-title":"J. Antibiot."},{"key":"10.1016\/j.mex.2025.103167_bib0020","series-title":"National Antibiotic Guideline","year":"2014"},{"key":"10.1016\/j.mex.2025.103167_bib0021","series-title":"National Antibiotic Guideline","year":"2024"},{"key":"10.1016\/j.mex.2025.103167_bib0022","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/bcp.15612","article-title":"Superiority of ceftazidime off-label high-dose regimen in PK\/PD target attainment during treatment of extensively drug-resistant Pseudomonas aeruginosa infections in cancer patients","volume":"89","author":"Zavrelova","year":"2023","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["MethodsX"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2215016125000159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2215016125000159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T17:00:27Z","timestamp":1771866027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2215016125000159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":22,"alternative-id":["S2215016125000159"],"URL":"https:\/\/doi.org\/10.1016\/j.mex.2025.103167","relation":{},"ISSN":["2215-0161"],"issn-type":[{"value":"2215-0161","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adaptation of an in vitro one-compartment pharmacodynamic chemostat for testing efficacy of ceftazidime against Burkholderia pseudomallei outside a BSL3 facility","name":"articletitle","label":"Article Title"},{"value":"MethodsX","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mex.2025.103167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103167"}}